Summit Tx Capital, L.P. Ptc Therapeutics, Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 20,749 shares of PTCT stock, worth $940,137. This represents 0.05% of its overall portfolio holdings.
Number of Shares
20,749Holding current value
$940,137% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
280Shares Held
77.9MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$390 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$352 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$339 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$246 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$246 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.24B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...